Novartis Kills $78M Noncompete Deal With Departing Chairman

Novartis AG on Tuesday scrapped a $78 million noncompete deal with departing chairman Daniel Vasella, marking the latest casualty in a global pushback against lucrative executive compensation packages and potentially impacting...

Already a subscriber? Click here to view full article